IOVA
Iovance Biotherapeutics Inc
$3.70
+4.52% (+$0.16)
Volume
10.58M
52W High
$5.63
52W Low
$1.66
Market Cap
$1.83B
Next Earnings Report
Last Reported
May 7, 2026 Missed
Actual: -$0.19
vs. Consensus: -$0.15
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
+1.97%
5-Day:
+0.28%
Q1 2026
Mar 31, 2026
1-Day:
-1.71%
Q4 2025
Feb 24, 2026
1-Day:
+1.32%
Q4 2025
Dec 31, 2025
5-Day:
-10.26%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $86.8M | +17.7% | 215.9% | -84.7% | -$71.9M |
| Q3'25 | $67.5M | +15.2% | 97.9% | -140.7% | -$91.3M |
| Q2'25 | $60.0M | +92.7% | 5.5% | -189.8% | -$111.7M |
| Q1'25 | $49.3M | +6,798.5% | -0.9% | -245.8% | -$116.2M |
| Q4'24 | $73.7M | +10,000.0% | 38.2% | -117.5% | -$78.6M |
| Q3'24 | $58.6M | +10,000.0% | 32.0% | -152.1% | -$83.5M |
| Q2'24 | $31.1M | +10,000.0% | -0.8% | -327.6% | -$97.1M |
| Q1'24 | $715,000 | -- | -915.5% | -10,000.0% | -$113.0M |
Company Information
Symbol
IOVA
Company
Iovance Biotherapeutics Inc
Market Cap
$1.83B